O16200

Size: px
Start display at page:

Download "O16200"

Transcription

1 Fe(3+) ) 21) 57) ppm 18), 24) 18) (1) : ; 1) 24) (2) : ; ) ; ; ppm30 (3) : ( ) ; ; (4) : 12 (5) : (7) * : 1 * : ( ) 1 ;

2 2 ; ; 23) *: *: * 11618) : : ) 1 27) (1) A. B. C. D. E. (2) A. : 100% 18) B. C. D. E. : 1 :1mg 5 : :0.5-1mg 5 2mg(0.04mg/kg) 0.5mg :0.02mg/kg 5 1mg 0.1mg F. : ; 1) / : 14) G. : X 1624)

3 3 (3) A ) (Hb)2 3 (Met-Hb) 3 18) [ ] 24) 1) 1 1 (0.25mL) ) 1 1 (0.25mL) 25) 100% 30 / ) ) 2) ( ) 3% 10mL 20 ( 1520 ) 10mL ) mLkg10mL ( 1520 ) 24) ) : B. (HBO) HBO HBO 10 * 12 (1) ( ) 15 (2) * 1

4 4 (1) (2) A. : (1) : (2) : 7) B. : ( ) [ ]Sulfurated hydrogen Hydrosulfuric acid Hydrogen sulfuric acid Sulfur hydride Stink DAMP 519) CAS No ) : 99.9% 417) ) 5) [ ]H2S [ ]34.08 [ ]1.188( =1)(251 )20)

5 5 [ ]0.96 [ ]1.384(nD) []-85.5 []-60.4 [ ] [ ]20mmHg(25.5) [ ]260 [ ]100.5 [ ]8.9 [ ]4.346% [ ](1g/242mL 20) (1g/94.3mL,20) 45) [ ] 20) ( ) (DMSO ) ( ), ( ) ( ) 4517) : 2 ( ) :2 ;17 ; 1 ( ) 3 (2 )417) 18 2 MSDS 36) 18) 500ppm ppm 1,, 24) :0.0047ppm :0.05ppm [ ], 24) 0.05ppm :

6 0.1 ppm : 50150ppm 250ppm ppm >500ppm : : : : ppm: 6%24) ppm 24) 24) 10ppm67 26) 250ppm 3 26) 24) 4100ppm 50500ppm 250ppm ppm 600ppm ppm 1000ppm 12 [ ] 500ppm ) ppm 24) % 24) ;LCLo:800ppm5 19) ;LCLo:600ppm ) ;LCLo:5700g/kg 1619) / mg/L 24) 6100ppm 24) 0.92mg/L 1.06mg/kg 0.38mg/kg 0.34mg/kg ppm 24) 0.45g/mL g/ml (0.014mmol/mL) (0.143mmol/mL) 2.72g/mL 5.04g/mL 6

7 7 (0.085mmol/mL) (0.045mmol/mL) 0.42g/mL 9.30g/mL (0.013mmol/mL) (0.083mmol/mL) 0.16g/mL (0.005mmol/mL) [ ( )] ;LC50:444ppm 19) ;LC50:634ppm1 19) ;LC:1.12mg/L(800ppm)1030 5) ;LC:1.5mg/L(1000ppm)15 5) ;LC:1.5mg/L(1000ppm)2 5) ;LC:1.4mg/L(900ppm) 5 5) ;LC:0.7mg/L(500ppm) 1 5) ;LC100:60ppm1 5) ;LC100:100ppm1 5) [ ] : : : [ ] ACGIH:TLV-TWA ;10ppm 4520) ACGIH: TLV-STEEL;15ppm 520) IDLH( ):300ppm Fe(3+) ) ( )1622) 21) 57)

8 8 2122) (H2S)HS(-)S(2-) ; 6100ppm 0.92mg/L1.06mg/L0.38mg/L0.34mg/L ppm 24) 0.45g/mL g/ml (0.014mmol/mL) (0.143mmol/mL) 2.72g/mL 5.04g/mL (0.085mmol/mL) (0.045mmol/mL) 0.42g/mL 9.30g/mL (0.013mmol/mL) (0.083mmol/mL) 0.16g/mL (0.005mmol/mL) 0.05mg/L 24) (1 LD 85% ) 521) 24) 1821) ppm 18), 24) 18) (1) : ; 1) 24) ;50400ppm

9 (2) : ; 1, 16, 18) ; ppm 24) ppm30 ; ppm48 600ppm30 18)250ppm ppm 24) 416% ) 24) 63 24) (3) : () 24) ; ; 50150ppm 250ppm 3 26) 500ppm30 24) >500ppm: ) ppm 24) ppm ( ) ; 20 CT mg/L 0.05mg/L 20 24) ( ) ( ) 222) (CT )13) 24) (4) : 12 ( ) 9

10 (5) : (7) * : 1 * : ( ) 1 1 ; ; ; 23) * : ; ppm67 26) 5060ppm 24) ppm; colored halos( gas eyes ) ( gas eyes ) 1, 5, 16, 18, 24) 1 *: ) 100ppm ) *: 24) * : ) * : 2000Hz 27) 3 27) 10 HSDB32) positive pressure self-contained breathing apparatus:scba 34)

11 11 HSDB)32) ) X 24) 24) (HBO)24) * 11618) : : ) 68 27) 1 27) (1) A. B. C. D. E. (2) A. : 100% 18) B. C. : 1 (1 ) (2 ) 1) 200mg 400mg mL 5% g/mL : 25g/kg/ 510g/kg/ : 2) 4mL(4mg)5% 1000mL 4g/mL : ;23mL(812g)/

12 12 ;0.10.2g/kg/ :0.51mL(24g)/ D. : 2472 ( ) : : ( ) : : 18) E. : 1 :1mg 5 : :0.51mg 5 2mg(0.04mg/kg) 0.5mg :0.02mg/kg 5 1mg 0.1mg F. : ; 1) 14) : G. : X, 24) 24) 24) 2 24) (3) A ) [ ] (Hb)2 3 (Met-Hb) 3

13 ) 18) [ ] CN(-) HS(-) ) 18) 1 24) 2 24) [ ] 24) 24) (1) 1 1 (0.25mL) ) 1 1 (0.25mL) 25) 100% 30 / ) ) 25) (2) ( ) 3% 20mL 0.6g 30) 3 10mL 20 ( 1520 ) 3 10mL 50100mL 24 29) 10mL )

14 mLkg10mL 20 ( 1520 ) 24) ( ) 2429) (g/dl) 3% 8g 0.22mL/kg 10g 0.27mL/kg 12g( ) 0.33mL/kg 14g 0.39mL/kg 129) : ( ) (Smith 1950) Na2S2O3 + CN(-) SCN(-) + Na2SO3 ( ) 8) [ ] ) 40% 9 12mg/kg(1%) 5mg/kg 3) : 80mmHg 7) ( ) 1) B. (HBO) HBO HBO 10) HBO : 2 100% HBO 1 : :75 2 :

15 15 (3 / 1 / 6 12 )10) HBO : - 10) 1012) 12) 10) * 12 (1) ( ) 15 (2) A. : B. : * 1 (1) (2) A. : (1) : 42C 4042C 1530 ( ) 1 2 (2) : 7) B. : * 5 5)

16 16 1) 3 30,48, (A) 48 (B) (C)30 46 B (-) Respirator 100 (C) (+) (-)Anisocolie(+) (+) Respirator 21% 60ppm24ppm 30ppm 0 800ppm A, B, C, 28) 2) ) 3) 1 44 (A)50 (B)58 (C) B AC C A CB A C DOA B %,,,5 12 X,CT ) 4)

17 % 2, %( 0.5% ) 1 5) ) ) ( )20) : 21,24) GC/MS 24) 1) (HSDB)32) m(330660feet) ( ) 60m(200feet) 0.2km (0.1miles) 0.5km(0.3miles) 125m(400feet) 0.3km (0.2miles) 1.4km(0.9miles) (HAZARDTEXT)33) 30m(100feet) 0.2km(0.1miles) 0.3km(0.2miles) 215m(700feet) 1.4km(0.9miles) 4.3km(2.7miles) 200L 200L 11km(7miles)

18 18 30 (HSDB)32) 1600m(1miles) 1600m(1miles) 2) (HSDB)32) 1) 2) 3) 4) (HSDB)32) 3) 34)

19 19 1.POISOINDEX ;53rd Edition 2.Clinical Toxicology of Commercial Products;5th Edition, ;< > ;, ;, ;, ;, FM Audeau etal;industrrial MEDICINE,Hydrogen sulphide poisoning; associated with pelt processing. New Zealand Med J 1985;13; Roger P.Smith;Hydrogen Sulfide Poisoning.Journal of Occup Med 1979;21; (DREISBACH;handbook of POISONING);, 1984 ", " 10.Martin J. Smilkstein et al;hyperbaric oxygen therapy for severe hydrogensulfide poisoning. The Journal of Emergency Medicine 1985;3; Jerry B.Vannatta;Hydrogen Sulfide poisoning. Report of Four Cases and Brief Review of the Literature. OSMA JOURNAL 1982; 75; Daniel D.Whitcraft;Hydrogen sulfide poisoning treated with hyperbaric oxygen. The Jounal of Emergency Medicine 1985;3; Fumisuke Matsuo;Neurological Sequelae of Massive Hydrogen Sulfide Inhalation. Arch Neurol 1979;36; Adriano G Ravizza.et al;the TREATMENT OF HYDROGEN SULFIDE INTOXI- CATION;OXYGEN VERSUS NITRITES. SCIENTIFIC REPORTS POISINDEX:HYDROGEN SULFIDE,VOL.96, ,, :,, NIOSH:Registry Toxic Effects of Chemical Substance,VOL.36, :,, Matthew J.E.& Donald G.B.:Medical Toxicology,2nd edition, Elsevier, Goldfrank,L.R. et al:toxicologic Emergencies,5th edition, Appleton-Century-Crofts, : ,40(3), , Rumack BH & Spoerke DG(eds): HYDROGEN SULFIDE,POISINDEX(R) Information System.MICROMEDEX,Inc., Colorado, VOL.115, pp pp pp

20 (1) Rumack BH & Spoerke DG(eds): CYANIDE POISINDEX(R) Information System.MICROMEDEX,Inc., Colorado, VOL.115, (10): Goldfrank,L.R. et al:toxicologic Emergencies,6th edition, Appleton-Century-Crofts, Hazardous Substance Data Bank:HYDROGEN SULFIDE,VOL.55, HAZARDTEXT(R):Hazard management:hydrogen SULFIDE,VOL.55, ,.,,1996,pp ,,:DOA ;8(4),pp ,,2002.pp ID O

Microsoft Word - O16200_硫化水素.doc

Microsoft Word - O16200_硫化水素.doc 硫化水素 0. 概要 0.9. 中毒学的薬理作用 チトクロムオキシダーゼ阻害作用硫化水素はシアンと同様 ミトコンドリア内のチトクロームオキシダーゼの Fe(3+) と結合し 酵素を阻害 細胞呼吸を障害し 低酸素症 中枢神経系細胞の直接障害を引き起こす 皮膚粘膜刺激作用水に溶けやすいため粘膜の水分に溶け 比較的低濃度で眼 気道 皮膚粘膜を刺激する 16 18 21) 中枢抑制 呼吸抑制作用高濃度では直ちに中枢抑制

More information

橡フタル酸ブチルベンジル.PDF

橡フタル酸ブチルベンジル.PDF 1 97 7 3 1312 CAS 85 68 7 O BBP 1, 2- C 19 H 20 O 4 312.4 C C O O O (CH 2 ) 3 1 99.9 % 1. 2-35 3 2, 3 370 3, 4 199 d 25 4 1.117 2 10.8 = 1 5 1.15 10-3 Pa 8.6 10-6 mmhg 20 5 253 Pa 1.9 mmhg 200 5 log Pow

More information

●70974_100_AC009160_KAPヘ<3099>ーシス自動車約款(11.10).indb

●70974_100_AC009160_KAPヘ<3099>ーシス自動車約款(11.10).indb " # $ % & ' ( ) * +, -. / 0 1 2 3 4 5 6 7 8 9 : ; < = >? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y " # $ % & ' ( ) * + , -. / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B

More information

橡99-24_00 アリルアルコール.PDF

橡99-24_00 アリルアルコール.PDF 1 9924 2260 CAS 107186 H 2 C CH CH 2 OH 2- -1- C 3 H 6 O 58.08 1 99 1. 2, 3 3, 4, 5-129 96-97 2 21c.c. 24o.c. 2 6, 7 378 6, 7 2.5-18 d 20 4 0.8540 2, 5 2.00 = 1 2.7 kpa 20 mmhg204.3 kpa 32 mmhg30 4 log

More information

CAS NC(CH 2 ) 4 CN 1,4- C 6 H 8 N c.c d = Pa

CAS NC(CH 2 ) 4 CN 1,4- C 6 H 8 N c.c d = Pa 1 200117 21512 CAS 111693 110 NC(CH 2 ) 4 CN 1,4- C 6 H 8 N 2 108.14 1 99 2-1. 2 1 295 159 c.c. 550 3 1.7-4.9 20 d 0.965 4 3.73 = 1 0.3 Pa 0.002 mmhg20 2 log Pow-0.32 m/z 41, 1.0 68 0.54 54 0.43 4 Koc9-16

More information

14 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 20 0 0 0 0 0 0 0 0 0 0 0 0 21 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 23 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0

More information

CAS O C O * DOP* DEHP 2- C O O * n- C 24 H 38 O CH 2 CH 2 CH 2 CH 3 CH (CH 2 ) % 2- A BHT , 4

CAS O C O * DOP* DEHP 2- C O O * n- C 24 H 38 O CH 2 CH 2 CH 2 CH 3 CH (CH 2 ) % 2- A BHT , 4 2-1 9628 31307 CAS 117817 2- O C O * DOP* DEHP 2- C O O * n- C 24 H 38 O 4 390.56 CH 2 CH 2 CH 2 CH 3 CH (CH 2 ) 3 1 99 % 2- ABHT 1. 2-55 3 3, 4 386 171 350 6 0.1 % d 20 4 0.9861 4 13.48 0.30410-4 Pa 2.2810-7

More information

98-02.PDF

98-02.PDF 1 982 2207 CAS 67630 2- H 3 C H 3 C CH OH C 3 H 8 O 60.10 1 99.9 % n- 1. 2-88.5 3 82.5 3 11.7c.c. 455 4 212 d 20 4 0.78505 3 2.1 = 1 4 4.4 kpa 33 mmhg20 4 log Pow0.05 0.07 5 m/z45, 1.0 43 0.19 27 0.17

More information

橡96-07.PDF

橡96-07.PDF 1 967 2482 CAS 50000 CH 2 O 30.03 2952% 12.5 % 1. 2) -92 2) -19.5 2) 5085 3) 424 3) 7.073.0% 4) 20 d 4 0.815 5) 1.03 ( = 1) 5) 1.33 kpa (10 mmhg) (-88.0) 2) log Pow0.35 ( ) 6) 0.35 ( ) 7) 1) m/z 29 ( 1.0

More information

橡アジポニトリル.PDF

橡アジポニトリル.PDF 1 200117 21512( ) CAS 111693 110( ) 1,4- NC(CH 2 ) 4 CN C 6 H 8 N 2 108.14 1) 99 2-1. 2) 1 2) 295 2) 159(c.c.) 3) 550 3) 1.7-4.9 vol % ( ) 3) d 20 0.965 2) 3.73 ( = 1) 4 0.3 Pa (0.002 mmhg) (20) 2) log

More information

,977 t 157,977 t mg l mg l BOD 9398 % OH = cm 3 / sec 11 = cm 3 / sec OH = /

,977 t 157,977 t mg l mg l BOD 9398 % OH = cm 3 / sec 11 = cm 3 / sec OH = / 1 9625 2219 CAS 75569 1, 2-1, 2- H 2 C CH CH 3 C 3 H 6 O 58.08 1 99 % 1. 2 2, 3-112.13 2, 3 34.23-37 449 2.8-37 % 2 d 0 4 0.859 4 d 20 0.8304 2 2, 4 2.00 = 1 53.33 kpa 400 mmhg18 59.33 kpa 445 mmhg20 5

More information

http://www.who.int/ipcs/publications/ehc/en/index.html EHC 1 2 3 4 / EHC http://www.nihs.go.jp/dcbi/publist/ehchsg/ 1-8) WHO/IPCS CICAD (Concise Inter

http://www.who.int/ipcs/publications/ehc/en/index.html EHC 1 2 3 4 / EHC http://www.nihs.go.jp/dcbi/publist/ehchsg/ 1-8) WHO/IPCS CICAD (Concise Inter 3 [ ] Priority IARC JMPR 2004 10 Priority 1 Priority 1 Priority 2 Priority 3 Priority 1 1-1) CERI) http://www.cerij.or.jp/ceri_jp/koukai/sheet/sheet_indx4.htm http://www.safe.nite.go.jp/data/sougou/pk_list.html?table_name=hyoka&rank=sh

More information

,309 t 22,069 t 7,240 t µg/l µg/l < ,431-70, , , mg/l m

,309 t 22,069 t 7,240 t µg/l µg/l < ,431-70, , , mg/l m 1 20019 1527 CAS 1317368 1230 PbO 223.20 1 99 1. 2 888 2 9.53 0.017 g/l 20 3 3 2 2. 10 29,309 t 22,069 t 7,240 t 4 1 3. 1 2 3.5 6 1 µg/l 9.1-24 2 µg/l < 43 6 27,431-70,000 4.5-1,300 13.4-17 31.7 0.48-3,459

More information

本文/一般演題_吉田

本文/一般演題_吉田 184 quality of lifeqol mmhg Hb gdl CA Uml Niveau Hb Hb gdl RCC CT MRI T 185 CT A B MRI A:T B:T Douglas red spot S ml RCC 186 A B mg CAUml S MRI A B 187 188 S mg Sampson JA. Intestinal adenomas of endometriosis

More information

t 492 t mg/l 30 mg/l BOD 95 OH = cm 3 / sec 25 8 OH /cm 3 12 = ph ph

t 492 t mg/l 30 mg/l BOD 95 OH = cm 3 / sec 25 8 OH /cm 3 12 = ph ph 2-1 200169 2740 CAS 110-49-6 1103 2- O H 3 C C O CH 2 CH 2 O CH 3 C 5 H 10 O 3 118.13 200168 2-1 99 2-1. 2 2, 3-65 2, 3 144145 45 o.c. 3 392 3 1.512.3 d19 1.009 2 4.07 = 1 30 Pa 0.23 mmhg20 2 4 log Pow0.10

More information

untitled

untitled 19 m 3 m 3 m 3 /s m 3 3 m 3 m 3 m 3 m 3 m 3 m 3 m 3 2km 2km 4km 3km 2km 2km 16km () 2km 2km 4km 4km 2km 2km 16km m 3 m 3 m 3 264,970 m 3 1,209.6 m 3 36,850 m 3 1,728 m 3 m 3 m 3 m 3 m 3 m 3 m 3 m

More information

3, ,104 t mg/l 30 mg/l BOD mg 14 C 8, /kg 11 8, 1 11 OH = cm 3 / sec 11 OH /cm ppm

3, ,104 t mg/l 30 mg/l BOD mg 14 C 8, /kg 11 8, 1 11 OH = cm 3 / sec 11 OH /cm ppm 3, 3-1 200019 4800 CAS 91941 1138 3, 3-4, 4 - -3, 3 - H 2 N Cl Cl NH 2 C 12 H 10 C l2 N 2 253.13 1 95 1. 2 3, 4 132-133 402 5 >200 5 700kg/m 3 5 8.73 = 1 5.610-8 kpa 4.210-7 mmhg20 4 6 log Pow3.51 3.57

More information

76

76 ! # % & % & %& %& " $ 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 % & &! & $ & " & $ & # & ' 91 92 $ % $'%! %(% " %(% # &)% & 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 !$!$ "% "%

More information

†ı25”Y„o-PDF.ren

†ı25”Y„o-PDF.ren 12,000 10,000 8,000 6,000 4,000 2,000 0 1998 1999 2000 2001 2002 2003 2004 1,200 1,000 800 600 400 200 0 1998 1999 2000 2001 2002 2003 2004 $ "! ''" '' ''$ ''% ''& '''! " ' & % $ "! ''" ' '$ '% '& ''!

More information

CAS H 3 C C CH 2 C 9 H tert d = hpa

CAS H 3 C C CH 2 C 9 H tert d = hpa 1 200140 35 CAS 98839 1335-2- H 3 C C CH 2 C 9 H 10 118.18 1 99 4-tert- 1. 2-23.2 2 163164 2 54 574 3 0.96.6 20 d 4 0.9082 2 4.07 = 1 2.5 hpa 1.9 mmhg20 2 4 log Pow3.48 3.44 m/z 118, 1.0 103 0.58 91 0.21

More information

橡三酸化二アンチモン.PDF

橡三酸化二アンチモン.PDF 1 2001 7 1 543( ) CAS 1309 64 4 1 25 ( ) Sb 2 O 3 291.52 1) 99 1. 2) 655 3) 1,425 3) ( ) 2) ( ) 2) ( ) 2) 5.2 ( ) 5.67 ( ) 3) 2) 2. 10 12,161 t ( 9,753 t 2,408 t) 4 2 1) 3. 1) 2) 3) 4. Selenastrum capricornutum

More information

,161 t 9,753 t 2,408 t LC 50 mg/ L EC 50 mg/l * 5 : Selenastrum 6772-h, Sb 2 O 3, : capricornutum 6 3 Selenastrum h, Sb

,161 t 9,753 t 2,408 t LC 50 mg/ L EC 50 mg/l * 5 : Selenastrum 6772-h, Sb 2 O 3, : capricornutum 6 3 Selenastrum h, Sb 1 20017 1543 CAS 1309644 125 Sb 2 O 3 291.52 1 99 1. 2 655 1,425 2 2 2 3 5.2 5.67 2 2 2. 10 12,161 t 9,753 t 2,408 t 4 3. 1 2 3 4. LC 50 mg/ L EC 50 mg/l * 5 : Selenastrum 6772-h, Sb 2 O 3, : capricornutum

More information

温泉の化学 1

温泉の化学 1 H O 1,003 516 149 124 2,237 1974 90 110 1km 2,400 ( 100 Mg 200 (98 ) 43,665 mg 38,695 mg 19,000 mg 2000 2000 Na-Ca-Cl 806 1970 1989 10 1991 4 ph 1 981 10,000 1993... (^^; (SO_4^{2-}) " " 1973-1987 1970

More information

23 3 11 24 21 24 25 4 28 4 2 7 161 2,692 28 12 14 18 18 380 5 3 1 27 21 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213 640 416 82,979

More information

2

2 1 3 11 21 2 3 28 42 33 12 31 11 4 21 46.5 30.0vol 30 36 16 DXNs 46 19 B 42 22 5 0.44 10 15 20 20 1.5 1.5 0.1 0.37 6 4.5 1.7 16 1.5 1.5 4.5 1.5 7 3.6 4.4 12 8 1.5 9 46 19 19 10 500ml 11 33 3.6 3.9 12 2.1

More information

- 1 - - 2 - 320 421 928 1115 12 8 116 124 2 7 4 5 428 515 530 624 921 1115 1-3 - 100 250-4 - - 5 - - 6 - - 7 - - 8 - - 9 - & & - 11 - - 12 - GT GT - 13 - GT - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - -

More information

2 3 5 5 5 5 6 6 7 7 8 10 10 10 10 11 11 12 12 13 16 16 16 16 17 19 21 21 22 5

2 3 5 5 5 5 6 6 7 7 8 10 10 10 10 11 11 12 12 13 16 16 16 16 17 19 21 21 22 5 1D000425-2 1 2 3 5 5 5 5 6 6 7 7 8 10 10 10 10 11 11 12 12 13 16 16 16 16 17 19 21 21 22 5 3 29 29 29 30 31 31 32 35 35 35 36 41 41 41 46 48 48 48 52 57 4 700 13 1988 4 5 4 5 21 1 1 3 4 5 6 21 10 1888

More information

経済論集 46‐2(よこ)(P)☆/2.三崎

経済論集 46‐2(よこ)(P)☆/2.三崎 1 2 1869 11 17 5 10 1 3 1914 5 15 5 1872 9 12 3 1870 1 26 14 1881 11 11 12 6 11 1878 5 9 13 1880 6 17 1 15 1882 1 2 3 11 1828 2 26 24 1891 4 22 2 1849 12 1 3 1856 pp 20 21. 1971 p.429. 1973 1, pp.440 444.

More information

橡96-01.PDF

橡96-01.PDF 1 961 31 CAS 71432 C 6 H 6 78.11 1) 99 % 1. 5.5 2) 80.1 2) -11 3) 293563 3) 1.48.0% 3) d 20 0.8786 4) 2.77 ( = 1) 4) 4 13.33 kpa (100 mmhg) (26.9) 2) log Pow2.13 ( ) 5) 2.14 ( ) 6) m/z78 ( 1.0 )77 ( 0.20

More information

JCOAL journal_Vol4(表紙)_0603

JCOAL journal_Vol4(表紙)_0603 JCOAL Journal vol.4 2006.3 01_ 02_ 12_ 25_ 29_ 33_ 01 JCOAL Journal JCOAL Journal 02 03 JCOAL Journal JCOAL Journal 04 05 JCOAL Journal JCOAL Journal 06 07 JCOAL Journal JCOAL Journal 08 s s s s s s s

More information

web用PDF作成用.indd

web用PDF作成用.indd 2013.9 Topics & Report Information 1 300 210 150 370 50 43.1 0.6 1.0 1.1 1.8 2.3 2.5 3.7 7.4 8.9 13.4 14.2 1 Topics & Report 2 Topics & Report 2 G O M E N K U N A N S Y O vol.102 3 Topics & Report 2 3

More information

23 3 11 21 24 28 4 31,371 20,822 34,511 21,720 12,278 9,574 7,502 137,778 1 69 83.49% 70 15.55% 0.96 3.61% 40 1.19% 1055 29.65% 28 10 1 2 230,250 43,150 656 138,000 137,832 137,820 121,000 30,000 246,800

More information

2

2 1 2 119 119 5 500 1 30 102 1 113 3 4 120 2 3 113 5 230 1 1 3 4 5 6 7 8 1 support@kansen.sakura.ne.jp 2 9 3 ( ) 10 11 12 4 1. 2. 3. 4. 13 5 14 15 16 17 18 19 [ ] [ ] 20 [ ] [ ] [ ] 21 22 [ ] 23 < > < >

More information

コロイド化学と界面化学

コロイド化学と界面化学 x 25 1 kg 1 kg = 1 l mmol dm -3 ----- 1000 mg CO 2 -------------------------------------250 mg Li + --------------------------------1 mg Sr 2+ -------------------- 10

More information

<4D F736F F D B BA908593B98AC782AB82E593E082CC88C091538AC7979D82C98AD682B782E992868AD495F18D908F912E646F63>

<4D F736F F D B BA908593B98AC782AB82E593E082CC88C091538AC7979D82C98AD682B782E992868AD495F18D908F912E646F63> 12 62 1800 14 3 11 14 4 14 4 30 ... 1... 1... 1... 2... 5... 6... 7... 10... 13... 18... 19 21 22 24 27 28 31 32 33... 34... 35... 37 2 1,650mm () H=2,500W=2,000 460m 750m 500m 42.1m 1.15m () 100% 80%

More information

平成26年度 化学物質分析法開発報告書

平成26年度 化学物質分析法開発報告書 N,N- N,N-Dimethylacetamide Acethyldimethylamine CAS 127-19-5 C 4 H 9 NO 87.12 ~ 87.14 87.68413 163-165 C 1) - 18.59 C 2) 1 mg/l 25 C 3) 3.3 hpa 2 C 4) log P ow -.77 2).9429 2/4 C 1) 3.1 4) 1.31E - 8 atm-m

More information

untitled

untitled FOUR SEASONS 2 JET Report vol.51 JET Report vol.51 3 4 JET Report vol.51 JET Report vol.51 5 6 JET Report vol.51 JET Report vol.51 7 8 JET Report vol.51 JET Report vol.51 9 10 JET Report vol.51 JET Report

More information

1 47 13 4 16 5 14-9 -

1 47 13 4 16 5 14-9 - 1 9 2 13 3 16 4 18 5 19 6 19 7 19 8 21 1 23 2 24 3 26 4 29 5 32 1 34 2 34 3 34 4 36 1 38 2 38 3 39 1 47 13 4 16 5 14-9 - - 10 - 1 16-10 1 14 12 5 7 0.030.05ppm 1 0.1ppm 0.04ppm 0.1ppm 2 [< 0.04] ppmppm

More information

Digital Series DS-00 5 6 5 P.7 5 P. 5 6 6 P.09 P.8 7 P.5 P.8 P.80 8 9 P. P. P.09 P.7 P. P.5 P.0 P.9 P.7 0 P.9 P. P.79 P.6 P.5 P.8 P.6 5 6 P. 7 P.9P. 8 P. 6 5 P.7 9 5 6 P. 0 6 5 P.7 5 6 P. 5 P.9 P.

More information

橡リシン

橡リシン 1 2 1 2 2), 3) 2 3 5, 4) 4 28 39, 4) 12 21 30 30 21 5, 5) Jatropha multifida 10 8.5 9.5 5 6) 4) 3, 5, 6 3 4) 8 2 LDLo 300 g/kg 7) - 1 - mg/kg: (LDLo) 2mg/kg 7) 30mg, 3) 1/2 2, 3) LDLo 7 g/kg 8 6 2 28,

More information

グリセオール注インタビューフォーム

グリセオール注インタビューフォーム 2006 8 3 873999 871319 IF 1998 9 FAX 1 200mL 300mL 500mL 20g 30g 50g 10g 15g 25g 1.8g 2.7g 4.5g 0.9W/V 200mL500mL 1979 3 13 2004 7 9 1979 5 15 2006 8 300mL 1979 3 13 2004 7 9 1982 11 1 IF 1 MR 63 IF 10

More information

橡アロマセラピー症状別処方例.PDF

橡アロマセラピー症状別処方例.PDF 1 1 92 E 100ml 1 2 2 1 93 0.5m 10ml 100ml 1 2 3 2 52 0. l 2 4 3 27 3 1 1 3 3 4 5 3 2g 2 3 1 1 1 10ml 3 4 6 3 29 2 2 2 10ml 3 3 4 7 3 30 2 1 2 10ml 3 3 4 8 3 31 1 1 1 1 3 60 10 10 3 2 4 10ml A 2 3 61 20

More information

Microsoft Word - ゴールドコーストマラソン2014.docx

Microsoft Word - ゴールドコーストマラソン2014.docx 2014 2014 7 3 7 14:25 16:20 22:25 6:25 10:55 19:00 22:55 0:35 42.195Km 7,300km 537,844 2013 6 30 6 2 1 Dr. 1 20 10 Q1 Q1 8m 2 7 4 15 J B H..S 45 30 7 20 49 20 15 3 45 4 3 50 28 35 km 40km 4 4 6 15km 20km

More information

untitled

untitled ...1... 3 1... 3 2... 4 3... 4 4... 5...... 6 1... 6 2... 7 3... 8 4... 9 5... 10... 12 1... 12 2... 13 3... 14 4... 16...... 19 1... 19 2... 20 3... 22 4... 24...... 25... 26 1... 26 2... 26 3... 26......

More information

7) G. N., A. A. Sondore et al.: The Use of Hyperbaric Oxygenation in Intensive Therapy of Patients with Liver Damage. VI Int. Cong. HBO Medicine, Moscow, Sept 2 `6:341, 1981 8) J. J. Moder, M. D.: Phagocytic

More information

14 4 12 10 8 6 3 2 4 2 1 0 0 100200300400500600 100200300400500600700 0 0 100200300400500600 100200300400500600700 (ppm) (ppm) 7 4 6 5 4 3 3 2 2 1 1 0 0 100200300400500600 100200300400500600700 0 0 100200300400500600

More information

untitled

untitled b 0 1PPm 10PPm 100PPm 1000PPm 10000PPm 0.0001% 0.001% 0.01% 0.1% 1% 10% 1PPm 10PPm 100PPm 1000PPm 10000PPm 0.0001% 0.001% 0.01% 0.1% 1% 10% 1PPm 10PPm 100PPm 1000PPm 10000PPm 0.0001% 0.001% 0.01%

More information

a new way of learning Japanese p2 p5 p8 p11 p13 CONTENTS p01-16_ことは の学ひ _別冊_No.10.indd 10 /?< #)' -= #)' #)' &)(.8 0 ",+B C ; ",+B C?1 7B C 3 7 $!%* $!%* $ " 254 > @6 A 9 : 254 ",+B C ",+B C $!%*

More information

財政金融統計月報第720号

財政金融統計月報第720号 ! # " $ % &! # % " $ &! # % " $ &! # %! # % " $ & " $ &! # % " $ & !!!!!!! !!!!!!! ! # " $ ! # " $ ! " # $! " # $ ! # " $ ! # $& %" !

More information

第3章 焼却灰溶融システムの現状、焼却灰溶融スラグのリサイクルの動向・問題点

第3章  焼却灰溶融システムの現状、焼却灰溶融スラグのリサイクルの動向・問題点 18 5 23 450 100~150 1300 1998 10 25 1 1 27 1819 60 3 300t 28.8t 2 62 118t16 12.3 16h 24 3 4 120t 9.6t24h 3 4 100t24h 15t24h 3 4 600t24h 500t24h 5 2 300t24h 75t24h 6 8 80 24h 9.6 24h 4 300t24h 52 24 11

More information

8 8 0

8 8 0 ,07,,08, 8 8 0 7 8 7 8 0 0 km 7 80. 78. 00 0 8 70 8 0 8 0 8 7 8 0 0 7 0 0 7 8 0 00 0 0 7 8 7 0 0 8 0 8 7 7 7 0 j 8 80 j 7 8 8 0 0 0 8 8 8 7 0 7 7 0 8 7 7 8 7 7 80 77 7 0 0 0 7 7 0 0 0 7 0 7 8 0 8 8 7

More information

(1) (2) (3) (1

(1) (2) (3) (1 21 9 1 1 2 1 (1)................................... 1 (2)..................................... 1 (3)..................................... 1 3 1 4 2 (1)................................ 2 (2).......................................

More information

PowerPoint プレゼンテーション

PowerPoint プレゼンテーション "# "# $%&' "#$% $# & $# $% % ' ()(*"#$% +,(- ()(*"#$%.' ()(* $/.0##'' %0$&0% 1*2#/0/%'&0343$56 789#/0/'%&04../ "3"0##"$ "0%0$" "7 1*2#.30///04%.$ 789#.30///0#$'4 http://www.ibie2016.com/exhibitorlist/

More information

2

2 J 2 3 " ' + # & $ % ( ) * " # $ % & ' Q ( ) * + 4 1 2 5 6 1 2 7 1 B 2 Q 3 8 V X 9 W q 10 V X W q 11 12 13 14 - - a 15 x M 16 A B C A B 17 1 2 3 a a 18 4 5 19 x M 20 Q 21 B A 22 1 2 1 l 23 2 3 Z 8:1 4:1

More information

% %

% % 4 8 4 5 414.5 172.1 41.5% 39.8 10% 17 186.4 70.8 4 9 10 11 3 1-1 - 2-2 - - 3 - 10% - 4 - 4060% 5560% 60% 40% 3040 1520 1015 411 7 4 11 610 7080 5060 100 3040 13-5 - 1015 4045 3.04.0 5.06.0 1.52.0 1.01.5

More information

2004 1

2004 1 2004 1 1 2 3 BIDBusiness Improvement District 4 5 6 1) 2) 7 8 1,000 30 5 50 1) 35 15 2) 25 30 3 2004 3 4) 5) 30 6 0.5 CB 7) 8) 9) 10) 11) 12) 13) 14) 15) 16) 100 5km 101 17) 9 -1 50 http://www.data.kishou.go.jp/etrn/index.html

More information

Microsoft Word - 14_LCMS_アクリルアミド

Microsoft Word - 14_LCMS_アクリルアミド 3--2-3-Iodo-2-propynyl butylcarbamate (IPBC) Carbamic acid, butyl-, 3-iodo-2-propynyl ester Iodocarb CAS 55406-53-6 C 8 H 12 NO 2 I C (g/cm 3 ) (mmhg) log P ow 281.09 (280.9910) 64 68 1.51 1.57 (20 C)

More information

untitled

untitled - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - - 28 - - 29 - - 30 -

More information

Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents

Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents D 012 Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents DATA : 1 DATA : 2 3 DATA : UNGITEC 1 1 DATA : 20pg/mL 1020pg/mL 10pg/mL (cut off 20pg/mL) 90.2%(37/41) 100%(85/85) 96.8%(122/126)

More information

1999年3月作成(新様式第1版) 

1999年3月作成(新様式第1版)  200622 19989 871313 1mL4mg JAN oxybuprocaine hydrochloridejan 2002621 20037 4 19667 1 FAX 2005 10 29607 05 1 63 () 103 2 3 49 111 4 Drug Safety Update 1. -------------------------------------1 2. -----------------------1

More information

20 57

20 57 56 20 57 58 59 12 60 ph 61 62 CCA 63 64 ( 1) 700 7.5 86% 54 17 71 2) 700 6.8 86% 50 15 65 3) 600 700 5.7 84% 36 14 50 550 650 4.2 80% 21 6 27 40 500 3.6 78% 16 7 23 3.6 78% 16 7 23 400 700 4.0 78% 18 7

More information

目次

目次 2007 04SG1156 1999 - i - 13 15 18 25 30 33 34 40 42 1 45 2 50 53 54 - ii - 1999 2000: 30 1946 WHO - 1 - 1999-2 - 1989-3 - 1885 18 1886 1891 24 11 1950 30 2001: 83 2001: 26 2001: 26 1) 41 4 43 1 43 3 4

More information

平成26年度 化学物質分析法開発報告書

平成26年度 化学物質分析法開発報告書 2,2-2,2 -Iminodiethanol Diethanol amine CAS 111-42-2 C 4 H 11 NO 2 105.1356-105.0790-28 C 1) 1.0881 g/cm 3 1)

More information

-----------------------------------------------------------------------------------------1 --------------------------------------------------------------------------------------1 -------------------------------------------------------------------------------------1

More information

›¼’à”v“lŠÍ1−ª

›¼’à”v“lŠÍ1−ª 3 1 1 2 3 4 5 6 7 8 8 10 12 14 16 18 20 22 24 2 1 2 3 4 5 6 7 8 9 10 11 12 26 28 30 32 34 36 38 40 42 44 46 48 50 4 3 1 2 3 4 5 52 54 56 58 60 6 62 7 8 9 10 64 66 68 70 72 5 1 1 4 2 5 6 6 7 1 8 1 9 2 10

More information